PORTLAND, Oregon, May 20, 2019 /PRNewswire/ -- Allied Market
Research recently published a report, titled, "STD
Testing Market (Sexually Transmitted Diseases Testing)
By Sexually Transmitted Disease Types (Chlamydia testing, Syphilis,
Gonorrhoea, Herpes Simplex Virus, Human Papilloma Virus, Human
Immunodeficiency Virus testing) and Type (Laboratory Testing and
Point of Care Testing) - Global Opportunity Analysis and Industry
Forecast, 2017–2025." According to the report, the global STD
testing market was accounted for $86.55
billion in 2017 and is expected to reach $133.93 billion in 2025, growing at a CAGR of
5.6% during the forecast period.
Growing prevalence of STD, implementation of national screening
programs, and supporting reimbursement for STD testing have fueled
the growth of the global STD testing market. On the other hand,
social stigma associated with patients visiting specialized STD
clinics, huge proportion of patients infected with STD in
out-of-reach geographic areas, and stringent regulatory abidance
requirements for the participants of STD market hamper the growth
to certain extent. However, decreasing number of visits to GUM
clinics and specialized STD clinics, several prospects for
technology, and POC test providers in the emerging economies are
expected to create multiple opportunities in the future.
Request Sample Report at:
https://www.alliedmarketresearch.com/request-sample/385
The Chlamydia Testing segment to rule the roost-
Based on disease type, the Chlamydia Testing segment held more
than one-fourth of the total market share in 2017 and is expected
to retain its dominance during the study period. This is attributed
to the wide prevalence of chlamydia across the world.
Simultaneously, the Gonorrhoea segment is projected to grow at the
highest CAGR of 8.9% by 2025.
The laboratory testing segment to remain dominant through
2025-
Based on testing type, the laboratory testing segment generated
the largest share in 2017, accounting for more than four-fifths of
the total market. Wide adoption of the method among end users has
driven the growth of the segment. The point of care testing
segment, on the other hand, is expected to grow at the highest CAGR
of 7.0% during the forecast period.
Asia-Pacific to maintain its
lion's share during the forecast period-
Based on region, Asia-Pacific
contributed to more than half of the total market share in 2017 and
is expected to dominate throughout 2019-2025. Rise in incidence of
sexually transmitted diseases across the region has spurred the
growth of the market in the region. Moreover, growing healthcare
awareness and increase in responsiveness for early screening or
diagnosis of the sexually transmitted diseases have accelerated the
growth in more than one way.
For Purchase Enquiry at:
https://www.alliedmarketresearch.com/purchase-enquiry/385
Key market players-
The report offers a detailed analysis of the key market players
and they include Roche Holdings AG, BioMerieux, Hologic Inc.,
Becton Dickinson & Company,
Cepheid Inc., Danaher Corporation, Affymetrix, Abbott Laboratories,
Bio-Rad Laboratories Inc., DiaSorin, and Orasure. These key players
are expanding the scope of their business operations by
incorporating innovative products in their product portfolios. They
have also adopted a plethora of strategies such as group effort,
partnerships, mergers & acquisitions, developments, joint
ventures, and others to strengthen their foothold in the
industry.
Access KNOWLEDGE TREE (Premium on-demand, subscription-based
pricing model) at:
https://www.alliedmarketresearch.com/knowledgetree
Knowledge tree is a cloud-based intelligence
platform that offers more than 2,000 selective, off-the-shelf
reports on niche markets to enable our clients gain deep insights
on the latest trends, dynamic technologies, and emerging
application areas.
Similar Reports:
HIV Drug Market - Global Opportunity Analysis and Industry
Forecast, 2017-2023
Cephalosporin Market - Global Opportunity Analysis and
Industry Forecast, 2018 – 2025
About Us
Allied Market Research (AMR) is a full-service market research
and business-consulting wing of Allied Analytics LLP based in
Portland, Oregon. Allied Market
Research provides global enterprises as well as medium and small
businesses with unmatched quality of "Market Research Reports" and
"Business Intelligence Solutions." AMR has a targeted view to
provide business insights and consulting to assist its clients to
make strategic business decisions and achieve sustainable growth in
their respective market domain.
We are in professional corporate relations with various
companies and this helps us in digging out market data that helps
us generate accurate research data tables and confirms utmost
accuracy in our market forecasting. Each and every data presented
in the reports published by us is extracted through primary
interviews with top officials from leading companies of domain
concerned. Our secondary data procurement methodology includes deep
online and offline research and discussion with knowledgeable
professionals and analysts in the industry.
Contact:
David
Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Logo:
https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg